Mediplantex National Pharmaceutical JSC (HNX:MED)
Vietnam · Delayed Price · Currency is VND 25,200
0.00 (0.00%)
At close: Nov 20, 2025
HNX:MED Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | 12,100 | 15,247 | 11,744 | 6,366 | 3,747 | 24,422 | Upgrade |
Depreciation & Amortization | 5,055 | 7,916 | 8,444 | 10,020 | 9,536 | 10,020 | Upgrade |
Loss (Gain) From Sale of Assets | 12,825 | -773.89 | -6,395 | -3,782 | -3,902 | -4,102 | Upgrade |
Other Operating Activities | -2,061 | 2,015 | -1,936 | 1,683 | -2,016 | -3,885 | Upgrade |
Change in Accounts Receivable | 35,041 | 23,261 | 37,508 | 2,063 | 58,829 | 63,652 | Upgrade |
Change in Inventory | 9,992 | 15,425 | -1,583 | -14,664 | 4,843 | 39,261 | Upgrade |
Change in Accounts Payable | -25,849 | -16,803 | -95,351 | 26,049 | -6,766 | -42,537 | Upgrade |
Change in Other Net Operating Assets | -3,215 | 1,368 | 3,660 | -1,503 | -2,160 | 2,524 | Upgrade |
Operating Cash Flow | 43,894 | 47,653 | -43,908 | 26,231 | 62,110 | 89,354 | Upgrade |
Operating Cash Flow Growth | - | - | - | -57.77% | -30.49% | -23.00% | Upgrade |
Capital Expenditures | 25,506 | -9,979 | -40,594 | -117,270 | -54,364 | -28,827 | Upgrade |
Sale of Property, Plant & Equipment | -43.64 | - | 43.64 | 240.21 | 992.27 | 8.18 | Upgrade |
Investment in Securities | -56,400 | 8,000 | 72,400 | -44,000 | 6,000 | - | Upgrade |
Other Investing Activities | 8,894 | 1,121 | 7,204 | 3,354 | 3,479 | 3,376 | Upgrade |
Investing Cash Flow | -22,043 | -858.42 | 39,054 | -157,676 | -43,893 | -54,843 | Upgrade |
Short-Term Debt Issued | - | 157,753 | 193,594 | 205,142 | 180,305 | 218,086 | Upgrade |
Total Debt Issued | 71,044 | 157,753 | 193,594 | 205,142 | 180,305 | 218,086 | Upgrade |
Short-Term Debt Repaid | - | -194,430 | -219,966 | -182,973 | -192,316 | -233,080 | Upgrade |
Total Debt Repaid | -59,270 | -194,430 | -219,966 | -182,973 | -192,316 | -233,080 | Upgrade |
Net Debt Issued (Repaid) | 11,774 | -36,676 | -26,372 | 22,168 | -12,012 | -14,995 | Upgrade |
Issuance of Common Stock | - | - | - | 153,104 | - | - | Upgrade |
Common Dividends Paid | -14,487 | -11,021 | -6,426 | -8,816 | -13,281 | -9,307 | Upgrade |
Financing Cash Flow | -2,712 | -47,697 | -32,799 | 166,456 | -25,293 | -24,302 | Upgrade |
Foreign Exchange Rate Adjustments | -22.43 | -19.53 | 2.9 | -28.96 | - | 10.42 | Upgrade |
Net Cash Flow | 19,117 | -922.47 | -37,650 | 34,983 | -7,076 | 10,219 | Upgrade |
Free Cash Flow | 69,401 | 37,674 | -84,502 | -91,039 | 7,746 | 60,527 | Upgrade |
Free Cash Flow Growth | - | - | - | - | -87.20% | -38.65% | Upgrade |
Free Cash Flow Margin | 19.53% | 8.50% | -20.98% | -22.70% | 2.25% | 11.61% | Upgrade |
Free Cash Flow Per Share | 5594.96 | 3035.74 | -6809.19 | -9696.32 | 1234.13 | 9638.35 | Upgrade |
Cash Interest Paid | 112.58 | 3,816 | 5,432 | 4,953 | 3,643 | 4,302 | Upgrade |
Cash Income Tax Paid | 104.13 | 3,874 | 4,719 | 272.58 | 2,383 | 9,020 | Upgrade |
Levered Free Cash Flow | 35,855 | 29,827 | -101,170 | -115,881 | 14,442 | 45,357 | Upgrade |
Unlevered Free Cash Flow | 36,434 | 32,195 | -97,798 | -112,754 | 16,703 | 48,992 | Upgrade |
Change in Working Capital | 15,970 | 23,250 | -55,765 | 11,945 | 54,746 | 62,900 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.